Trial Profile
Phase II Study of Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Apr 2021
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Copanlisib (Primary) ; Gemcitabine (Primary)
- Indications Biliary cancer; Carcinoma; Cholangiocarcinoma; Gallbladder cancer
- Focus Therapeutic Use
- 08 Dec 2020 Status changed from active, no longer recruiting to completed, according to results presented in the cancer.
- 08 Dec 2020 Results of Phase II study of copanlisib in combination with gemcitabine and cisplatin in advanced biliary tract cancers published in the Cancer.
- 02 Dec 2020 Planned End Date changed from 1 Dec 2020 to 1 Jul 2021.